Compare Stocks

2 / 10
Try these comparisons:

Stock Comparison

KEQU vs VIRC

Revenue, margins, valuation, and 5-year total return — side by side.

Live fundamentals10-year financials5-year price chart
KEQU
Kewaunee Scientific Corporation

Furnishings, Fixtures & Appliances

Consumer CyclicalNASDAQ • US
Market Cap$106M
5Y Perf.+287.4%
VIRC
Virco Mfg. Corporation

Furnishings, Fixtures & Appliances

Consumer CyclicalNASDAQ • US
Market Cap$96M
5Y Perf.+160.5%

KEQU vs VIRC — Key Financials

Market cap, revenue, margins, and valuation side-by-side.

Company Snapshot
KEQU logoKEQU
VIRC logoVIRC
IndustryFurnishings, Fixtures & AppliancesFurnishings, Fixtures & Appliances
Market Cap$106M$96M
Revenue (TTM)$288M$237M
Net Income (TTM)$11M$14M
Gross Margin28.9%42.6%
Operating Margin7.0%7.7%
Forward P/E24.2x8.5x
Total Debt$50M$42M
Cash & Equiv.$15M$27M

KEQU vs VIRCLong-Term Stock Performance

Price return indexed to 100 at period start. Dividends excluded.

KEQU
VIRC
StockMay 20May 26Return
Kewaunee Scientific… (KEQU)100387.4+287.4%
Virco Mfg. Corporat… (VIRC)100260.5+160.5%

Price return only. Dividends and distributions are not included.

Quick Verdict: KEQU vs VIRC

Each card shows where this stock fits in a portfolio — not just who wins on paper.

Bottom line: VIRC leads in 5 of 7 categories, making it the strongest pick for valuation and capital efficiency and profitability and margin quality. Kewaunee Scientific Corporation is the stronger pick specifically for growth and revenue expansion and recent price momentum and sentiment. As sector peers, any of these can serve as alternatives in the same allocation.
KEQU
Kewaunee Scientific Corporation
The Growth Play

KEQU is the clearest fit if your priority is growth exposure and long-term compounding.

  • Rev growth 18.0%, EPS growth -40.0%, 3Y rev CAGR 12.5%
  • 141.5% 10Y total return vs VIRC's 72.0%
  • 18.0% revenue growth vs VIRC's -1.1%
Best for: growth exposure and long-term compounding
VIRC
Virco Mfg. Corporation
The Income Pick

VIRC carries the broadest edge in this set and is the clearest fit for income & stability and sleep-well-at-night.

  • Dividend streak 1 yrs, beta 0.86, yield 1.5%
  • Lower volatility, beta 0.86, Low D/E 38.3%, current ratio 2.98x
  • Beta 0.86, yield 1.5%, current ratio 2.98x
Best for: income & stability and sleep-well-at-night
See the full category breakdown
CategoryWinnerWhy
GrowthKEQU logoKEQU18.0% revenue growth vs VIRC's -1.1%
ValueVIRC logoVIRCLower P/E (8.5x vs 24.2x)
Quality / MarginsVIRC logoVIRC5.7% margin vs KEQU's 3.9%
Stability / SafetyVIRC logoVIRCBeta 0.86 vs KEQU's 1.09, lower leverage
DividendsVIRC logoVIRC1.5% yield; 1-year raise streak; the other pay no meaningful dividend
Momentum (1Y)KEQU logoKEQU+19.0% vs VIRC's -26.4%
Efficiency (ROA)VIRC logoVIRC6.8% ROA vs KEQU's 5.9%, ROIC 18.8% vs 18.3%

KEQU vs VIRC — Revenue Breakdown by Segment

How each company's revenue is distributed across its business units

KEQUKewaunee Scientific Corporation
FY 2025
Domestic Operations
74.6%$179M
International Operations
25.4%$61M
VIRCVirco Mfg. Corporation

Segment breakdown not available.

KEQU vs VIRC — Financial Metrics

Side-by-side numbers across 2 stocks — who leads on profitability, valuation, growth, and risk.

BEST OVERALLVIRCLAGGINGKEQU

Income & Cash Flow (Last 12 Months)

VIRC leads this category, winning 4 of 6 comparable metrics.

KEQU and VIRC operate at a comparable scale, with $288M and $237M in trailing revenue. Profitability is closely matched — net margins range from 5.7% (VIRC) to 3.9% (KEQU). On growth, KEQU holds the edge at +3.3% YoY revenue growth, suggesting stronger near-term business momentum.

MetricKEQU logoKEQUKewaunee Scientif…VIRC logoVIRCVirco Mfg. Corpor…
RevenueTrailing 12 months$288M$237M
EBITDAEarnings before interest/tax$26M$24M
Net IncomeAfter-tax profit$11M$14M
Free Cash FlowCash after capex$19M$2M
Gross MarginGross profit ÷ Revenue+28.9%+42.6%
Operating MarginEBIT ÷ Revenue+7.0%+7.7%
Net MarginNet income ÷ Revenue+3.9%+5.7%
FCF MarginFCF ÷ Revenue+6.6%+0.9%
Rev. Growth (YoY)Latest quarter vs prior year+3.3%-15.1%
EPS Growth (YoY)Latest quarter vs prior year-48.9%-37.5%
VIRC leads this category, winning 4 of 6 comparable metrics.

Valuation Metrics

VIRC leads this category, winning 6 of 6 comparable metrics.

At 4.6x trailing earnings, VIRC trades at a 52% valuation discount to KEQU's 9.7x P/E. On an enterprise value basis, VIRC's 3.3x EV/EBITDA is more attractive than KEQU's 6.3x.

MetricKEQU logoKEQUKewaunee Scientif…VIRC logoVIRCVirco Mfg. Corpor…
Market CapShares × price$106M$96M
Enterprise ValueMkt cap + debt − cash$141M$111M
Trailing P/EPrice ÷ TTM EPS9.66x4.60x
Forward P/EPrice ÷ next-FY EPS est.24.18x8.55x
PEG RatioP/E ÷ EPS growth rate0.08x
EV / EBITDAEnterprise value multiple6.27x3.30x
Price / SalesMarket cap ÷ Revenue0.44x0.36x
Price / BookPrice ÷ Book value/share1.66x0.91x
Price / FCFMarket cap ÷ FCF8.40x3.57x
VIRC leads this category, winning 6 of 6 comparable metrics.

Profitability & Efficiency

VIRC leads this category, winning 8 of 9 comparable metrics.

KEQU delivers a 15.9% return on equity — every $100 of shareholder capital generates $16 in annual profit, vs $12 for VIRC. VIRC carries lower financial leverage with a 0.38x debt-to-equity ratio, signaling a more conservative balance sheet compared to KEQU's 0.76x. On the Piotroski fundamental quality scale (0–9), VIRC scores 5/9 vs KEQU's 4/9, reflecting solid financial health.

MetricKEQU logoKEQUKewaunee Scientif…VIRC logoVIRCVirco Mfg. Corpor…
ROE (TTM)Return on equity+15.9%+11.8%
ROA (TTM)Return on assets+5.9%+6.8%
ROICReturn on invested capital+18.3%+18.8%
ROCEReturn on capital employed+15.1%+21.0%
Piotroski ScoreFundamental quality 0–945
Debt / EquityFinancial leverage0.76x0.38x
Net DebtTotal debt minus cash$35M$15M
Cash & Equiv.Liquid assets$15M$27M
Total DebtShort + long-term debt$50M$42M
Interest CoverageEBIT ÷ Interest expense4.64x32.34x
VIRC leads this category, winning 8 of 9 comparable metrics.

Total Returns (Dividends Reinvested)

KEQU leads this category, winning 6 of 6 comparable metrics.

A $10,000 investment in KEQU five years ago would be worth $30,795 today (with dividends reinvested), compared to $19,703 for VIRC. Over the past 12 months, KEQU leads with a +19.0% total return vs VIRC's -26.4%. The 3-year compound annual growth rate (CAGR) favors KEQU at 32.2% vs VIRC's 19.2% — a key indicator of consistent wealth creation.

MetricKEQU logoKEQUKewaunee Scientif…VIRC logoVIRCVirco Mfg. Corpor…
YTD ReturnYear-to-date-1.3%-3.3%
1-Year ReturnPast 12 months+19.0%-26.4%
3-Year ReturnCumulative with dividends+131.2%+69.5%
5-Year ReturnCumulative with dividends+207.9%+97.0%
10-Year ReturnCumulative with dividends+141.5%+72.0%
CAGR (3Y)Annualised 3-year return+32.2%+19.2%
KEQU leads this category, winning 6 of 6 comparable metrics.

Risk & Volatility

VIRC leads this category, winning 2 of 2 comparable metrics.

VIRC is the less volatile stock with a 0.86 beta — it tends to amplify market swings less than KEQU's 1.09 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. VIRC currently trades 64.9% from its 52-week high vs KEQU's 60.8% drawdown — a narrower gap to the peak suggests stronger recent price momentum.

MetricKEQU logoKEQUKewaunee Scientif…VIRC logoVIRCVirco Mfg. Corpor…
Beta (5Y)Sensitivity to S&P 5001.09x0.86x
52-Week HighHighest price in past year$60.89$9.36
52-Week LowLowest price in past year$30.78$5.16
% of 52W HighCurrent price vs 52-week peak+60.8%+64.9%
RSI (14)Momentum oscillator 0–10058.550.9
Avg Volume (50D)Average daily shares traded5K38K
VIRC leads this category, winning 2 of 2 comparable metrics.

Analyst Outlook

VIRC leads this category, winning 1 of 1 comparable metric.

VIRC is the only dividend payer here at 1.47% yield — a key consideration for income-focused portfolios.

MetricKEQU logoKEQUKewaunee Scientif…VIRC logoVIRCVirco Mfg. Corpor…
Analyst RatingConsensus buy/hold/sellBuy
Price TargetConsensus 12-month target
# AnalystsCovering analysts1
Dividend YieldAnnual dividend ÷ price+1.5%
Dividend StreakConsecutive years of raises01
Dividend / ShareAnnual DPS$0.09
Buyback YieldShare repurchases ÷ mkt cap+1.5%+4.0%
VIRC leads this category, winning 1 of 1 comparable metric.
Key Takeaway

VIRC leads in 5 of 6 categories (Income & Cash Flow, Valuation Metrics). KEQU leads in 1 (Total Returns).

Best OverallVirco Mfg. Corporation (VIRC)Leads 5 of 6 categories
Loading custom metrics...

KEQU vs VIRC: Frequently Asked Questions

10 questions · data-driven answers · updated daily

01

Is KEQU or VIRC a better buy right now?

For growth investors, Kewaunee Scientific Corporation (KEQU) is the stronger pick with 18.

0% revenue growth year-over-year, versus -1. 1% for Virco Mfg. Corporation (VIRC). Virco Mfg. Corporation (VIRC) offers the better valuation at 4. 6x trailing P/E (8. 5x forward), making it the more compelling value choice. Analysts rate Virco Mfg. Corporation (VIRC) a "Buy" — based on 1 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

02

Which has the better valuation — KEQU or VIRC?

On trailing P/E, Virco Mfg.

Corporation (VIRC) is the cheapest at 4. 6x versus Kewaunee Scientific Corporation at 9. 7x. On forward P/E, Virco Mfg. Corporation is actually cheaper at 8. 5x.

03

Which is the better long-term investment — KEQU or VIRC?

Over the past 5 years, Kewaunee Scientific Corporation (KEQU) delivered a total return of +207.

9%, compared to +97. 0% for Virco Mfg. Corporation (VIRC). Over 10 years, the gap is even starker: KEQU returned +141. 5% versus VIRC's +72. 0%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

04

Which is safer — KEQU or VIRC?

By beta (market sensitivity over 5 years), Virco Mfg.

Corporation (VIRC) is the lower-risk stock at 0. 86β versus Kewaunee Scientific Corporation's 1. 09β — meaning KEQU is approximately 28% more volatile than VIRC relative to the S&P 500. On balance sheet safety, Virco Mfg. Corporation (VIRC) carries a lower debt/equity ratio of 38% versus 76% for Kewaunee Scientific Corporation — giving it more financial flexibility in a downturn.

05

Which is growing faster — KEQU or VIRC?

By revenue growth (latest reported year), Kewaunee Scientific Corporation (KEQU) is pulling ahead at 18.

0% versus -1. 1% for Virco Mfg. Corporation (VIRC). On earnings-per-share growth, the picture is similar: Virco Mfg. Corporation grew EPS -1. 5% year-over-year, compared to -40. 0% for Kewaunee Scientific Corporation. Over a 3-year CAGR, VIRC leads at 12. 9% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

06

Which has better profit margins — KEQU or VIRC?

Virco Mfg.

Corporation (VIRC) is the more profitable company, earning 8. 1% net margin versus 4. 7% for Kewaunee Scientific Corporation — meaning it keeps 8. 1% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: VIRC leads at 10. 5% versus 7. 4% for KEQU. At the gross margin level — before operating expenses — VIRC leads at 43. 1%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

07

Is KEQU or VIRC more undervalued right now?

On forward earnings alone, Virco Mfg.

Corporation (VIRC) trades at 8. 5x forward P/E versus 24. 2x for Kewaunee Scientific Corporation — 15. 6x cheaper on a one-year earnings basis.

08

Which pays a better dividend — KEQU or VIRC?

In this comparison, VIRC (1.

5% yield) pays a dividend. KEQU does not pay a meaningful dividend and should not be held primarily for income.

09

Is KEQU or VIRC better for a retirement portfolio?

For long-horizon retirement investors, Virco Mfg.

Corporation (VIRC) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 86), 1. 5% yield). Both have compounded well over 10 years (VIRC: +72. 0%, KEQU: +141. 5%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

10

What are the main differences between KEQU and VIRC?

Both stocks operate in the Consumer Cyclical sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.

In terms of investment character: KEQU is a small-cap high-growth stock; VIRC is a small-cap deep-value stock. VIRC pays a dividend while KEQU does not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.

Find Stocks Like These

Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform both.

Stocks Like

KEQU

Quality Business

  • Sector: Consumer Cyclical
  • Market Cap > $100B
  • Gross Margin > 17%
Run This Screen
Stocks Like

VIRC

Stable Dividend Mega-Cap

  • Sector: Consumer Cyclical
  • Market Cap > $100B
  • Net Margin > 5%
  • Dividend Yield > 0.5%
Run This Screen
Custom Screen

Beat Both

Find stocks that outperform KEQU and VIRC on the metrics below

Revenue Growth>
%
(KEQU: 3.3% · VIRC: -15.1%)
Net Margin>
%
(KEQU: 3.9% · VIRC: 5.7%)
P/E Ratio<
x
(KEQU: 9.7x · VIRC: 4.6x)

You Might Also Compare

Based on how these companies actually compete and overlap — not just which sector they're filed under.